B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFMG |
Texto Completo: | http://hdl.handle.net/1843/60754 |
Resumo: | Background – Hepatocarcinogenesis is a multistep process that lead to genetic changes in hepatocytes resulting in neoplasia. However, the mechanisms of malignant transformation seem to differ widely. To know carcinogenesis mechanisms is essential to develop new treatment and prevention methods. Objective – The aim of this study is to analyze B-Raf protein immunoexpression in explants with hepatocellular carcinoma (HCC) related to hepatitis C (HCV), in adjacent cirrhotic tissue and in normal livers. We also associated the immunoexpression with known HCC related histopathogical prognostic features. Methods – Livers from 35 patients with HCV related cirrhosis and HCC that underwent liver transplantation or hepatectomy at Clinical Hospital – UFMG and 25 normal livers from necropsy archives were studied. Tumors were classified according to: tumor size, vascular invasion and differentiation grade. B-Raf protein expression was determined by immunohistochemistry. Results – B-Raf was strongly expressed in the HCV cirrhotic parenchyma cytoplasm of 17.1% cases and in 62.9% of HCC samples. Strong B-Raf protein staining was associated with tumor tissue (P<0.0001; OR=8.18 (2.62–26.63)). All normal livers showed weak or negative expression for B-Raf. There was no significant association among B-Raf scores and tumor differentiation grade (P=0.9485), tumor size (P=0.4427) or with vascular invasion (P=0.2666). Conclusion – We found B-Raf protein immunostaining difference in normal livers, in the areas of HCV cirrhosis and in the hepatocarcinoma. We did not find association between B-Raf expression and histopathological markers of tumor progression. Our data suggests that B-Raf may play an important role in initial HCC carcinogenesis. Larger studies are needed to validate these observation. |
id |
UFMG_3520b83f481792600de90a8b49431069 |
---|---|
oai_identifier_str |
oai:repositorio.ufmg.br:1843/60754 |
network_acronym_str |
UFMG |
network_name_str |
Repositório Institucional da UFMG |
repository_id_str |
|
spelling |
2023-11-09T22:11:02Z2023-11-09T22:11:02Z2021-1058441942310.1590/s0004-2803.202100000-7616784219http://hdl.handle.net/1843/60754Background – Hepatocarcinogenesis is a multistep process that lead to genetic changes in hepatocytes resulting in neoplasia. However, the mechanisms of malignant transformation seem to differ widely. To know carcinogenesis mechanisms is essential to develop new treatment and prevention methods. Objective – The aim of this study is to analyze B-Raf protein immunoexpression in explants with hepatocellular carcinoma (HCC) related to hepatitis C (HCV), in adjacent cirrhotic tissue and in normal livers. We also associated the immunoexpression with known HCC related histopathogical prognostic features. Methods – Livers from 35 patients with HCV related cirrhosis and HCC that underwent liver transplantation or hepatectomy at Clinical Hospital – UFMG and 25 normal livers from necropsy archives were studied. Tumors were classified according to: tumor size, vascular invasion and differentiation grade. B-Raf protein expression was determined by immunohistochemistry. Results – B-Raf was strongly expressed in the HCV cirrhotic parenchyma cytoplasm of 17.1% cases and in 62.9% of HCC samples. Strong B-Raf protein staining was associated with tumor tissue (P<0.0001; OR=8.18 (2.62–26.63)). All normal livers showed weak or negative expression for B-Raf. There was no significant association among B-Raf scores and tumor differentiation grade (P=0.9485), tumor size (P=0.4427) or with vascular invasion (P=0.2666). Conclusion – We found B-Raf protein immunostaining difference in normal livers, in the areas of HCV cirrhosis and in the hepatocarcinoma. We did not find association between B-Raf expression and histopathological markers of tumor progression. Our data suggests that B-Raf may play an important role in initial HCC carcinogenesis. Larger studies are needed to validate these observation.engUniversidade Federal de Minas GeraisUFMGBrasilMED - DEPARTAMENTO DE CLÍNICA MÉDICAArquivos de GastroenterologiaCarcinoma, HepatocellularProto-Oncogene Proteins B-rafHepacivirusHepatocellular carcinomaB-Rafhepatitis C virusB-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.1590/S0004-2803.202100000-76Paula Piedade GarciaRonniel Morais AlbuquerqueFernanda Maria Farage OsórioCláudia Alves CoutoAgnaldo Soares LimaPaula Vieira Teixeira Vidigalapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/60754/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALB-RAF PROTEIN IMMUNOEXPRESSION IN HEPATOCELLULAR CARCINOMA DUE TO HEPATITIS C VIRUS RELATED CIRRHOSIS pdfa.pdfB-RAF PROTEIN IMMUNOEXPRESSION IN HEPATOCELLULAR CARCINOMA DUE TO HEPATITIS C VIRUS RELATED CIRRHOSIS pdfa.pdfapplication/pdf487093https://repositorio.ufmg.br/bitstream/1843/60754/2/B-RAF%20PROTEIN%20IMMUNOEXPRESSION%20IN%20HEPATOCELLULAR%20CARCINOMA%20DUE%20TO%20HEPATITIS%20C%20VIRUS%20RELATED%20CIRRHOSIS%20pdfa.pdf242000c480c3ba6a732d5e0e01da21ffMD521843/607542023-11-09 20:49:57.174oai:repositorio.ufmg.br:1843/60754Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2023-11-09T23:49:57Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
dc.title.pt_BR.fl_str_mv |
B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis |
title |
B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis |
spellingShingle |
B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis Paula Piedade Garcia Hepatocellular carcinoma B-Raf hepatitis C virus Carcinoma, Hepatocellular Proto-Oncogene Proteins B-raf Hepacivirus |
title_short |
B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis |
title_full |
B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis |
title_fullStr |
B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis |
title_full_unstemmed |
B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis |
title_sort |
B-raf protein immunoexpression in hepatocellular carcinoma due to hepatitis c virus related cirrhosis |
author |
Paula Piedade Garcia |
author_facet |
Paula Piedade Garcia Ronniel Morais Albuquerque Fernanda Maria Farage Osório Cláudia Alves Couto Agnaldo Soares Lima Paula Vieira Teixeira Vidigal |
author_role |
author |
author2 |
Ronniel Morais Albuquerque Fernanda Maria Farage Osório Cláudia Alves Couto Agnaldo Soares Lima Paula Vieira Teixeira Vidigal |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Paula Piedade Garcia Ronniel Morais Albuquerque Fernanda Maria Farage Osório Cláudia Alves Couto Agnaldo Soares Lima Paula Vieira Teixeira Vidigal |
dc.subject.por.fl_str_mv |
Hepatocellular carcinoma B-Raf hepatitis C virus |
topic |
Hepatocellular carcinoma B-Raf hepatitis C virus Carcinoma, Hepatocellular Proto-Oncogene Proteins B-raf Hepacivirus |
dc.subject.other.pt_BR.fl_str_mv |
Carcinoma, Hepatocellular Proto-Oncogene Proteins B-raf Hepacivirus |
description |
Background – Hepatocarcinogenesis is a multistep process that lead to genetic changes in hepatocytes resulting in neoplasia. However, the mechanisms of malignant transformation seem to differ widely. To know carcinogenesis mechanisms is essential to develop new treatment and prevention methods. Objective – The aim of this study is to analyze B-Raf protein immunoexpression in explants with hepatocellular carcinoma (HCC) related to hepatitis C (HCV), in adjacent cirrhotic tissue and in normal livers. We also associated the immunoexpression with known HCC related histopathogical prognostic features. Methods – Livers from 35 patients with HCV related cirrhosis and HCC that underwent liver transplantation or hepatectomy at Clinical Hospital – UFMG and 25 normal livers from necropsy archives were studied. Tumors were classified according to: tumor size, vascular invasion and differentiation grade. B-Raf protein expression was determined by immunohistochemistry. Results – B-Raf was strongly expressed in the HCV cirrhotic parenchyma cytoplasm of 17.1% cases and in 62.9% of HCC samples. Strong B-Raf protein staining was associated with tumor tissue (P<0.0001; OR=8.18 (2.62–26.63)). All normal livers showed weak or negative expression for B-Raf. There was no significant association among B-Raf scores and tumor differentiation grade (P=0.9485), tumor size (P=0.4427) or with vascular invasion (P=0.2666). Conclusion – We found B-Raf protein immunostaining difference in normal livers, in the areas of HCV cirrhosis and in the hepatocarcinoma. We did not find association between B-Raf expression and histopathological markers of tumor progression. Our data suggests that B-Raf may play an important role in initial HCC carcinogenesis. Larger studies are needed to validate these observation. |
publishDate |
2021 |
dc.date.issued.fl_str_mv |
2021-10 |
dc.date.accessioned.fl_str_mv |
2023-11-09T22:11:02Z |
dc.date.available.fl_str_mv |
2023-11-09T22:11:02Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1843/60754 |
dc.identifier.doi.pt_BR.fl_str_mv |
10.1590/s0004-2803.202100000-76 |
dc.identifier.issn.pt_BR.fl_str_mv |
16784219 |
identifier_str_mv |
10.1590/s0004-2803.202100000-76 16784219 |
url |
http://hdl.handle.net/1843/60754 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.none.fl_str_mv |
Arquivos de Gastroenterologia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.publisher.initials.fl_str_mv |
UFMG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
MED - DEPARTAMENTO DE CLÍNICA MÉDICA |
publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
instname_str |
Universidade Federal de Minas Gerais (UFMG) |
instacron_str |
UFMG |
institution |
UFMG |
reponame_str |
Repositório Institucional da UFMG |
collection |
Repositório Institucional da UFMG |
bitstream.url.fl_str_mv |
https://repositorio.ufmg.br/bitstream/1843/60754/1/License.txt https://repositorio.ufmg.br/bitstream/1843/60754/2/B-RAF%20PROTEIN%20IMMUNOEXPRESSION%20IN%20HEPATOCELLULAR%20CARCINOMA%20DUE%20TO%20HEPATITIS%20C%20VIRUS%20RELATED%20CIRRHOSIS%20pdfa.pdf |
bitstream.checksum.fl_str_mv |
fa505098d172de0bc8864fc1287ffe22 242000c480c3ba6a732d5e0e01da21ff |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
repository.mail.fl_str_mv |
|
_version_ |
1803589440434601984 |